This study aims to determine plasma concentrations of MMP-2 and MMP-9, as well as clinical and laboratory parameters related to obesity throughout the follow-up period, to investigate the associations between these markers and the effects of weight loss in patients undergoing bariatric surgery. The gene discussed is MMP2; the disease is obesity due to melanocortin 4 receptor deficiency.